Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment.
Clin Gastroenterol Hepatol
2024
22
5
994-1004.e10
DOTA-based plectin-1 targeted contrast agent enables detection of pancreatic cancer in human tissue.
Angew Chem Int Ed Engl
2024
Hourglass, a compass navigating global and regional heterogeneity of pancreatic cancer†.
J Pathol
2024
263
1
5-7
OCaR1 endows exocytic vesicles with autoregulatory competence by preventing uncontrolled Ca2+ release, exocytosis, and pancreatic tissue damage.
J Clin Invest
2024
134
7
Dynamics and cytokinic regulation of immune cell infiltration in genetically engineered mouse models of pancreatic cancer dictate the sensitivity to immunotherapy.
Cancer Commun (Lond)
2024
44
1
178-182